SPY329.98+3.32 1.02%
DIA266.59+1.11 0.42%
IXIC11,185.59+180.73 1.64%

Karyopharm Announces Selinexor Clinical Data to be Presented at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Virtual Conference on Therapeutics for COVID-19

Encouraging Anti-Viral and Anti-Inflammatory Activity Demonstrated in a Subset of Patients in a Study of Low Dose Selinexor in Hospitalized Patients with Severe COVID-19 − − A Case Report From a COVID-19

· 10/06/2020 08:01

Encouraging Anti-Viral and Anti-Inflammatory Activity Demonstrated in a Subset of Patients in a Study of Low Dose Selinexor in Hospitalized Patients with Severe COVID-19 −
− A Case Report From a COVID-19 Patient Treated with Selinexor Now Also Published in the Annals of Case Reports -